Biojiva LLC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

RT001 · Diabetes
RT001 is a small molecule drug that targets the SGLT1 and SGLT2 transporters.

Phase 1 pipeline

BRX011

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Biojiva LLC portfolio CI brief
Biojiva LLC pipeline updates RSS

Frequently asked questions about Biojiva LLC

What is Biojiva LLC's pipeline?

Biojiva LLC has 1 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include RT001.

Sector hub: All tracked pharma companies